Mirum Pharmaceuticals 2025 Annual Meeting results: three directors elected

Mirum Pharmaceuticals, Inc.

Class III directors elected: Laura Brege (17.97M for, 18.17M withheld), Michael Grey (30.78M for), Christopher Peetz (35.98M for).
Ratified Ernst & Young as independent auditor for FY2025: 43.12M for, 19.2K against, 19.4K abstentions.
Advisory vote on executive compensation approved: 34.67M for, 1.46M against, 8.9K abstentions.
Broker non-votes of 7.02M on director elections and compensation proposals.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.